Brian A. Pollok
Papers
2
Total Citations
184
H-Index
2
About
Brian A. Pollok is a distinguished researcher whose work has fundamentally advanced the fields of drug discovery and cellular signaling. His primary research areas encompass ultra-high throughput screening technologies, protein kinase and phosphatase biology, and antiviral drug development. Pollok’s most significant contribution is the development of a FRET (Fluorescence Resonance Energy Transfer)-based assay platform for ultra-high density drug screening, a landmark innovation that has garnered over 160 citations. This technology revolutionized the identification of inhibitors targeting protein kinases and phosphatases, which are critical regulators of cell proliferation, apoptosis, and metabolism. By enabling rapid, miniaturized screening, his work accelerated the discovery of potential therapeutics for cancer and other diseases driven by aberrant phosphorylation. Additionally, Pollok contributed to antiviral research through a collaborative program focused on discovering inhibitors of the Hepatitis C virus NS2/3 protease, a key target for combating HCV infection. His pioneering efforts in assay design and high-throughput screening have left a lasting impact on pharmaceutical research, providing tools that continue to empower scientists in unraveling complex biological pathways and developing targeted therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2